These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
270 related items for PubMed ID: 23928467
1. Association of high post-transplant soluble CD30 serum levels with chronic allograft nephropathy. Grenzi PC, Campos ÉF, Tedesco-Silva H, Felipe CR, Franco MF, Soares MF, Medina-Pestana JO, Gerbase-Delima M. Transpl Immunol; 2013 Dec; 29(1-4):34-8. PubMed ID: 23928467 [Abstract] [Full Text] [Related]
8. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection. Slavcev A, Lácha J, Honsová E, Sajdlová H, Lodererová A, Vitko S, Skibová J, Striz I. Transpl Immunol; 2005 Jun; 14(2):117-21. PubMed ID: 15935302 [Abstract] [Full Text] [Related]
9. HLA antibodies and soluble CD30 are associated with poor renal graft outcome: updated results of a single-center cross-sectional study. Langan LL, D'Orsogna L, Park LP, Hughes TL, Irish A, Luxton G, Witt CS, Christiansen FT. Clin Transpl; 2006 Jun; ():219-25. PubMed ID: 18365380 [Abstract] [Full Text] [Related]
10. Post-transplant increased levels of serum sCD30 is a marker for prediction of kidney allograft loss in a 5-year prospective study. Delgado JC, Pavlov IY, Shihab FS. Transpl Immunol; 2009 Dec; 22(1-2):1-4. PubMed ID: 19772921 [Abstract] [Full Text] [Related]